首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2126431

家庭檢體收集市場：策略性洞察與預測（2026-2035 年）

Home Sample Collection Market - Strategic Insights and Forecasts (2026-2035)

出版日期: 2026年08月12日 | 出版商:

Knowledge Sourcing Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計家庭檢體採集市場將以 11.4% 的複合年成長率成長，從 2026 年的 25.6 億美元成長到 2035 年的 67.8 億美元。

全球居家檢體市場正經歷強勁成長，這主要得益於分散式醫療模式的日益普及以及對便利診斷服務需求的不斷成長。該市場透過遠端採集生物檢體，同時保持實驗室層級的分析流程，為分散式診斷提供支援。隨著醫療系統透過以患者為中心的診斷模式推動預防性篩檢、慢性病監測和個人化醫療，市場需求不斷成長。現場檢體採集面臨許多操作限制，例如預約安排、地理位置限制和醫護人員配備等，常常導致診斷檢測延誤。診斷服務供應商正在開發使用者友善的採集設備、數位化指導平台和安全的運輸系統，以提高樣本完整性並擴大檢體範圍。由於準確的診斷結果需要在整個檢測過程中使用高品質的生物檢體，因此該市場依賴標準化的採集流程、檢體穩定性、物流管理、法規遵循和檢查室整合。隨著消費者越來越習慣在家管理自身健康，感染疾病診斷、基因檢測、腫瘤學、女性健康和慢性病管理等領域的需求也不斷成長。這些趨勢不斷鞏固了居家檢體採集作為現代診斷服務重要組成部分的地位。

市場促進因素

分散式醫療保健模式的廣泛應用

隨著患者越來越傾向於選擇減少對醫院和門診依賴的醫療服務，分散式醫療正在擴大診斷服務的覆蓋範圍。醫療服務提供者推薦遠距離診斷以幫助早期發現疾病並提高患者便利性，因此對遠距診斷的需求也在成長。傳統的檢體採集方式有容量限制，因為它需要訓練有素的人員、預約管理以及醫療機構專用的採集基礎設施。診斷公司正在擴展居家檢體採集服務、數位化教育工具和整合檢測流程，以提高可近性並維持分析品質。分散式醫療正在推動檢驗的居家檢體採集解決方案的長期需求。

對預防醫學和個人化醫療的需求日益成長

在預防醫學領域，定期診斷檢測的重要性日益凸顯，因為疾病的早期發現有助於及時介入並改善臨床療效。隨著消費者擴大參與傳統醫療機構以外的健康檢查、基因分析和慢性病監測，對定期檢測的需求也不斷成長。在傳統的診斷流程中，就醫和預約等待時間等問題阻礙了人們定期參與，導致檢測頻率降低。醫療服務提供者正在拓展居家檢體採集計畫、個人化檢測服務和數位化健康平台，以促進預防醫學的普及，同時提高消費者的參與度。定期居家檢體採集有助於更廣泛地應用個人化醫療策略。

遠端醫療和數位健康服務的擴展

數位健康平台正在推動遠距醫療的發展，遠距醫療越來越依賴無需面對面諮詢即可產生的檢測數據，並增強居家診斷能力。隨著患者期望獲得整合了檢體採集、檢測分析和醫生諮詢等環節的整體醫療保健體驗，需求也在不斷成長。醫生通常需要客觀的檢測資訊來進行診斷和製定治療方案，這使得獨立的遠距醫療在臨床應用方面有其限制。診斷服務提供者正在將居家檢體採集套裝與數位化訂購系統、電子健康記錄和遠端醫療平台整合。這不僅提高了醫療服務的連續性，也支持了遠距患者管理。這種整合的醫療保健生態系統正在推動對居家檢體採集服務的持續需求。

自採集裝置的技術進步

創新的樣本採集技術正在提升檢體品質。這是因為簡化的採集設備減少了在臨床環境之外進行檢體採集時的操作誤差。隨著越來越多的消費者尋求可靠的居家診斷體驗，並希望獲得檢查室級的分析效能，市場對這類技術的需求也不斷成長。傳統的樣本採集方法需要專家指導，因為檢體的完整性取決於標準化的採集流程和處理規範。製造商正在開發改良的採血針、唾液採集裝置、穩定培養基和數位化指導工具，這些產品在提高易用性的同時，也能在運輸過程中維持檢體品質。這些技術創新增強了人們對居家檢體採集的信心，使其能夠應用於各種診斷領域。

市場限制因素

未經訓練的使用者不當採集檢體會損害檢體完整性並降低診斷準確性。對溫度敏感的生物檢體需要專門的運輸和物流，從而增加營運成本。監管機構對自採集設備的檢驗要求延長了產品開發週期和商業化。

依樣本類型
- 血液檢體
- 唾液樣本
- 尿液檢體
- 糞便檢體
- 鼻咽拭子檢體
- 口腔黏膜拭子檢體
- 其他樣本類型
透過使用
- 傳染病檢查
- 基因檢測
- 癌症篩檢和監測
- 慢性病監測
- 女性健康檢查
- 健康與預防保健檢測
- 其他用途
最終用戶
- 個人消費者
- 診斷檢查室
- 醫院和診所
- 製藥公司和臨床研究機構
透過分銷管道
- 直接面對消費者的網站
- 網路藥房
- 零售藥房
- 診斷服務供應商

第10章區域分析

北美洲
歐洲
亞太地區
拉丁美洲
中東和非洲

第11章國別分析

北美洲
歐洲
亞太地區
世界其他地區

第12章競爭格局

市佔率分析
競爭基準
策略舉措
併購
夥伴關係與合作

第13章：公司簡介

Everly Health, Inc.
LetsGetChecked
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings（Labcorp）
myLAB Box, Inc.
Vitagene, Inc.
Color Health, Inc.
Healthy.io Ltd.
ixlayer Inc.
Thriva Ltd.
Verisana Laboratories
Diagnox Health Inc.
Nurx, Inc.
Everlywell
Dante Labs Srl

第14章：商業市場預測

市場預測：依樣品類型
市場預測：按應用領域分類
市場預測：依最終用戶分類
市場預測：按地區分類

第15章投資與資金籌措分析

創業投資
戰略投資
家庭診斷領域資金籌措趨勢
新興射擊團體

第16章：未來展望

新興市場的商業機會
技術藍圖
去中心化診斷的未來
策略建議
概括

簡介目錄

Product Code: KSI-009149

The Home Sample Collection Market is forecast to grow at a CAGR of 11.4%, reaching USD 6.78 billion in 2035 from USD 2.56 billion in 2026.

The global home sample collection market is experiencing robust growth, driven by the increasing adoption of decentralized healthcare models and the rising demand for convenient diagnostic services. This market supports decentralized diagnostics by allowing biological specimens to be collected remotely while preserving laboratory-grade analytical workflows. Demand is increasing as healthcare systems encourage preventive screening, chronic disease monitoring, and personalized medicine through patient-centric diagnostic models. Facility-based specimen collection creates operational limitations because scheduling appointments, geographic accessibility, and healthcare workforce availability frequently delay diagnostic testing. Diagnostic service providers are developing user-friendly collection devices, digital instruction platforms, and secure transportation systems that improve sample integrity while expanding access to laboratory testing. The market depends on standardized collection procedures, specimen stability, logistics management, regulatory compliance, and laboratory integration because accurate diagnostic outcomes require high-quality biological samples throughout the testing process. Demand is expanding across infectious disease diagnostics, genetic testing, oncology, women's health, and chronic disease management as consumers become more comfortable managing healthcare from home. These developments continue positioning home sample collection as an essential component of modern diagnostic services.

Market Drivers

Growing Adoption of Decentralized Healthcare Models

Decentralized healthcare expands diagnostic accessibility because patients increasingly prefer healthcare services that reduce dependence on hospitals and outpatient clinics. Demand is increasing as healthcare providers encourage remote diagnostics that improve patient convenience while supporting earlier disease detection. Traditional specimen collection creates capacity constraints because healthcare facilities require trained personnel, appointment scheduling, and dedicated collection infrastructure. Diagnostic companies are expanding home collection services, digital education tools, and integrated laboratory workflows that improve accessibility while maintaining analytical quality. Decentralized healthcare strengthens long-term demand for validated home sample collection solutions.

Rising Demand for Preventive and Personalized Healthcare

Preventive healthcare increases the importance of routine diagnostic testing because early disease identification supports timely intervention and improved clinical outcomes. Demand is increasing as consumers participate more frequently in wellness screening, genetic analysis, and chronic disease monitoring outside traditional healthcare environments. Conventional diagnostic pathways reduce testing frequency because travel requirements and appointment delays discourage routine participation. Healthcare organizations are expanding home collection programs, personalized testing services, and digital health platforms that improve consumer engagement while strengthening preventive healthcare adoption. Routine home specimen collection supports broader implementation of personalized healthcare strategies.

Expansion of Telemedicine and Digital Health Services

Digital healthcare platforms strengthen home diagnostics because remote consultations increasingly depend on laboratory data generated without in-person clinical visits. Demand is increasing as patients expect integrated healthcare experiences that connect specimen collection, laboratory analysis, and physician consultations through digital ecosystems. Standalone telemedicine consultations provide limited clinical value because physicians frequently require objective laboratory information for diagnosis and treatment planning. Diagnostic providers are integrating home collection kits with digital ordering systems, electronic health records, and telehealth platforms that improve continuity of care while supporting remote patient management. Connected healthcare ecosystems reinforce sustained demand for home sample collection services.

Technological Advancements in Self-Collection Devices

Innovative collection technologies improve specimen quality because simplified collection devices reduce user errors during sample collection outside clinical settings. Demand is increasing as consumers seek reliable home diagnostic experiences that maintain laboratory-quality analytical performance. Conventional collection methods require professional supervision because specimen integrity depends on standardized collection procedures and handling protocols. Manufacturers are developing improved lancets, saliva collection devices, stabilization media, and digital instructional tools that enhance usability while preserving specimen quality during transportation. Technological innovation strengthens confidence in home sample collection across multiple diagnostic applications.

Market Restraints

Improper specimen collection by untrained users may compromise sample integrity and reduce diagnostic accuracy. Temperature-sensitive biological specimens require specialized transportation and logistics that increase operational costs. Regulatory validation requirements for self-collection devices extend product development timelines and commercialization processes.

Technology and Segment Insights

By Sample Type

Blood samples represent the largest segment because they support a broad range of clinical laboratory tests, including metabolic panels, cardiovascular biomarkers, hormone analysis, and chronic disease monitoring. Demand is increasing as healthcare providers encourage routine testing outside hospitals. Diagnostic companies are expanding capillary blood collection technologies, microsampling devices, and specimen stabilization systems that improve user convenience while preserving analytical accuracy. Saliva samples are gaining popularity for genetic and hormone testing due to ease of collection. Urine and stool samples support various diagnostic applications, including infectious disease and gastrointestinal testing. Nasal, throat, and buccal swab samples are essential for respiratory and genetic testing.

By Application

Infectious disease testing represents one of the fastest-growing applications because timely diagnosis supports early treatment and effective disease containment. Demand is increasing as consumers seek convenient diagnostic solutions that reduce unnecessary healthcare visits during symptomatic illness. Genetic testing is a significant and growing application, driven by consumer interest in ancestry and health risk assessment. Cancer screening and monitoring, chronic disease monitoring, women's health testing, and wellness and preventive health testing represent additional key applications driving demand for home collection services.

By End User

Individual consumers represent the largest end-user segment because growing health awareness and digital healthcare adoption continue shifting diagnostic services toward patient-centered care. Demand is increasing as consumers seek greater convenience, privacy, and flexibility while managing preventive healthcare and routine testing. Diagnostic laboratories utilize home collection to expand their service reach. Hospitals and clinics integrate home collection for patient monitoring. Pharmaceutical and clinical research organizations use home collection for decentralized clinical trials.

Competitive and Strategic Outlook

The competitive landscape features specialized direct-to-consumer health platforms and established diagnostic laboratory companies. Everly Health, Inc. differentiates itself through its comprehensive direct-to-consumer healthcare platform combining home sample collection, accredited laboratory testing, and telehealth services. LetsGetChecked offers a broad portfolio of home health tests supported by physician review and digital consultation. Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings (Labcorp) leverage their extensive laboratory networks and logistics capabilities. myLAB Box, Inc. specializes in direct-to-consumer diagnostic testing with a focus on confidential home collection for infectious diseases and sexual health. Color Health, Inc. combines preventive healthcare programs, genetic testing, and digital population health solutions. Healthy.io Ltd. specializes in smartphone-enabled diagnostic technologies. ixlayer Inc. provides digital diagnostic infrastructure connecting home collection, laboratories, and healthcare organizations.
Strategic developments include expanding disease-specific testing portfolios, strengthening digital care capabilities, and improving logistics networks. Companies are forming partnerships with healthcare organizations, employers, and research institutions. Product launches focus on improved collection devices, digital engagement tools, and integrated health platforms. Companies that successfully combine high-quality specimen collection with integrated digital healthcare ecosystems are expected to strengthen their competitive positions.

Conclusion

The home sample collection market is poised for substantial growth, driven by the adoption of decentralized healthcare, rising demand for preventive and personalized medicine, and technological advancements. The evolution from a convenience-driven service toward an essential component of decentralized diagnostics is reshaping healthcare delivery. Companies that successfully deliver reliable, user-friendly, and digitally integrated collection solutions are expected to lead the market. Ongoing technological innovation, regulatory support, and expanding consumer acceptance will further accelerate adoption throughout the forecast period.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. Executive Summary

1.1 Market Snapshot
1.2 Key Findings
1.3 Market Scope
1.4 Research Methodology
1.5 Analyst Perspective

2. Market Introduction

2.1 Market Definition
2.2 Market Evolution
2.3 Home Sample Collection Ecosystem
2.4 Types of Samples Collected at Home
2.5 Comparison with Conventional Sample Collection
2.6 Market Stakeholders
2.7 Value Chain Analysis

3. Market Overview

3.1 Market Outlook
3.2 Demand-Supply Analysis
3.3 Key Market Trends
3.4 Technology Advancements
3.5 Consumer Adoption Trends
3.6 Digital Health & Telemedicine Integration
3.7 Regulatory Environment Overview

4. Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5. Industry Landscape

5.1 Industry Value Chain Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
5.4 Reimbursement Landscape
5.5 Porter's Five Forces Analysis

6. Innovation Landscape

6.1 Self-Collection Technologies
6.2 Sample Stabilization Technologies
6.3 Digital Sample Tracking Solutions
6.4 AI & Automation in Sample Processing
6.5 Future Innovation Pipeline

7. Regulatory Landscape

7.1 United States
7.2 Europe
7.3 Asia Pacific
7.4 International Quality Standards
7.5 Regulatory Challenges for Home Collection Kits

8. Market Landscape

8.1 Market Adoption Analysis
8.2 Consumer Behavior Analysis
8.3 Distribution Ecosystem
8.4 Competitive Benchmarking

9. Market Segmentation

9.1 By Sample Type
- 9.1.1 Blood Samples
- 9.1.2 Saliva Samples
- 9.1.3 Urine Samples
- 9.1.4 Stool Samples
- 9.1.5 Nasal & Throat Swab Samples
- 9.1.6 Buccal Swab Samples
- 9.1.7 Other Sample Types
9.2 By Application
- 9.2.1 Infectious Disease Testing
- 9.2.2 Genetic Testing
- 9.2.3 Cancer Screening & Monitoring
- 9.2.4 Chronic Disease Monitoring
- 9.2.5 Women's Health Testing
- 9.2.6 Wellness & Preventive Health Testing
- 9.2.7 Other Applications
9.3 By End User
- 9.3.1 Individual Consumers
- 9.3.2 Diagnostic Laboratories
- 9.3.3 Hospitals & Clinics
- 9.3.4 Pharmaceutical & Clinical Research Organizations
9.4 By Distribution Channel
- 9.4.1 Direct-to-Consumer Websites
- 9.4.2 Online Pharmacies
- 9.4.3 Retail Pharmacies
- 9.4.4 Diagnostic Service Providers